“…The 2013 international ERS/ATS guidelines classify severe asthma as a disease that requires treatment with high doses of inhaled corticosteroids (ICS) and/or systemic corticosteroids in order to obtain symptom control or which remains problematic despite this therapy. 25 Any of the criteria outlined in Table 2 qualifies a patient as having ongoing symptoms and therefore severe asthma that needs referring to a specialist centre that offers a multidisciplinary service utilising a team experienced in the assessment and management of difficult asthma. 26 Severe asthma requires systematic evaluation for confounding factors and exacerbating triggers and, equally importantly, confirmation that asthma is the correct diagnosis by a multidisciplinary team.…”
“…The 2013 international ERS/ATS guidelines classify severe asthma as a disease that requires treatment with high doses of inhaled corticosteroids (ICS) and/or systemic corticosteroids in order to obtain symptom control or which remains problematic despite this therapy. 25 Any of the criteria outlined in Table 2 qualifies a patient as having ongoing symptoms and therefore severe asthma that needs referring to a specialist centre that offers a multidisciplinary service utilising a team experienced in the assessment and management of difficult asthma. 26 Severe asthma requires systematic evaluation for confounding factors and exacerbating triggers and, equally importantly, confirmation that asthma is the correct diagnosis by a multidisciplinary team.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.